Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy

Blood Cancer J. 2022 Nov 24;12(11):160. doi: 10.1038/s41408-022-00752-z.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19* / complications
  • Humans
  • Monoclonal Gammopathy of Undetermined Significance* / complications
  • Monoclonal Gammopathy of Undetermined Significance* / diagnosis
  • Paraproteinemias* / complications
  • Paraproteinemias* / diagnosis